RCKSX
Price
$19.41
Change
-$0.01 (-0.05%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

RCKSX vs VIMSX

Header iconRCKSX vs VIMSX Comparison
Open Charts RCKSX vs VIMSXBanner chart's image
Rock Oak Core Growth
Price$19.41
Change-$0.01 (-0.05%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RCKSX vs VIMSX Comparison Chart
Loading...
VS
RCKSX vs. VIMSX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKSX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. RCKSX (12.4M). VIMSX pays higher dividends than RCKSX: VIMSX (1.38) vs RCKSX (0.65). RCKSX was incepted earlier than VIMSX: RCKSX (20 years) vs VIMSX (26 years). VIMSX is a more actively managed with annual turnover of: 13.00 vs. RCKSX (12.00). RCKSX has a lower initial minimum investment than VIMSX: RCKSX (2000) vs VIMSX (3000). RCKSX annual gain was more profitable for investors over the last year : 29.20 vs. VIMSX (25.11). VIMSX return over 5 years is better than : 56.75 vs. RCKSX (20.08).
RCKSXVIMSXRCKSX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years26 years-
Gain YTD15.53612.557124%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets12.4M172B0%
Annual Yield % from dividends0.651.3847%
Returns for 1 year29.2025.11116%
Returns for 3 years9.279.8294%
Returns for 5 years20.0856.7535%
Returns for 10 years42.92128.2133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma